These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8018635

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Passage of the menopause is followed by haemostatic changes.
    Lindoff C, Petersson F, Lecander I, Martinsson G, Astedt B.
    Maturitas; 1993 Jul; 17(1):17-22. PubMed ID: 8412839
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Circulating Fibronectin and Plasminogen Activator Inhibitor-2 Levels as Possible Predictors of Recurrent Placental Syndrome: An Exploratory Study.
    Severens-Rijvers CAH, Al-Nasiry S, Ghossein-Doha C, Marzano S, Ten Cate H, Winkens B, Spaanderman MAE, Peeters LLH.
    Gynecol Obstet Invest; 2017 Jul; 82(4):355-360. PubMed ID: 27644043
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Fibrinolysis parameters in Sudanese women with severe preeclampsia.
    Elzein HO, Muddathir AR, Rida M, Rayis DA, Elhassan EM, Adam I.
    Hypertens Pregnancy; 2016 Nov; 35(4):559-564. PubMed ID: 27598010
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Involvement of fibrinolytic factors in mid trimester amniotic fluid with development of severe early-onset preeclampsia.
    Adachi T, Nakabayashi M, Sakura M, Ando K.
    Semin Thromb Hemost; 1999 Nov; 25(5):447-50. PubMed ID: 10625200
    [Abstract] [Full Text] [Related]

  • 37. Plasma fibronectin levels in normal pregnancy and pre-eclampsia: a preliminary report.
    Thurnau GR, Morgan MA, Brubaker D, Romine M, Blackshaw C, Fishburne JI, Fishburne I.
    Int J Gynaecol Obstet; 1987 Dec; 25(6):441-4. PubMed ID: 2892701
    [Abstract] [Full Text] [Related]

  • 38. Tissue plasminogen activator and plasminogen activator inhibitors of type 1 and type 2 in the plasma of parturient women.
    Uszyński M, Uszyński W, Zekanowska E, Garbacz J, Kielkowski A, Marcinkowski Z.
    J Perinat Med; 1996 Dec; 24(4):339-45. PubMed ID: 8880631
    [Abstract] [Full Text] [Related]

  • 39. Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia.
    Madazli R, Budak E, Calay Z, Aksu MF.
    BJOG; 2000 Apr; 107(4):514-8. PubMed ID: 10759271
    [Abstract] [Full Text] [Related]

  • 40. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A, Jurkowski P, Kotschy M, Ciecierski M, Jawień A.
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.